Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–36
Headlines
411
Sources here
4
Companies here
21
Current section Brazil Healthcare news
Latest

finance.yahoo.com Earnings

Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is BioMarin Pharmaceutical (BMRN) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. BioMarin Pharmaceutical is one of 914 individual stocks …

Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s

[US Food and Drug Administration (FDA)] Lantheus Holdings (LNTH [https://seekingalpha.com/symbol/LNTH]) on Friday announced the FDA approval of Tauklarify, a radiodiagnostic agent designed to identify tau pathology of the brain in adults with Alzheimer’s disease through positron emission tomography (PET). Specifically, the approval allows the …

BIIB34 mentioned
Sharemaestro market context Trend signal active 52 weeks +38.9% BIIB34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Mark Cuban says your 401(k) is ‘part of the cost of health care problem.’ Do you dump Big Insurance and own your values?

Photo by Nicola Gell / Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. If your retirement savings are invested in a broad index fund, Mark Cuban says you may be helping America's largest health …

H1UM34 mentioned C1NC34 mentioned
Sharemaestro market context Trend signal active 52 weeks +26.2% H1UM34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Zacks.com featured highlights include BioMarin Pharmaceutical, Invesco, Centene Corporation, Hewlett Packard Enterprise and Gibraltar Industries

For Immediate Release Chicago, IL – August 14, 2026 – Stocks in this week's article are BioMarin Pharmaceutical BMRN, Invesco IVZ, Centene Corporation CNC, Hewlett Packard Enterprise HPE and Gibraltar Industries ROCK. 5 Undervalued Price-to-Book Stocks Worth Buying in August There are several different …

B1MR34 main company C1NC34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +3.3% · Next-week setup negative 37.8% B1MR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Monolithic Power Systems and Las Vegas Sands have been highlighted as Zacks Bull and Bear of the Day

For Immediate Release Chicago, IL – August 14, 2026 – Zacks Equity Research shares Monolithic Power Systems MPWR as the Bull of the Day and Las Vegas Sands LVS as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Cardinal …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Centene (CNC) Stock Still Looks Like A Bargain As Shares Jumped 145%

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Centene stock has surged over the past year, yet the current checks still suggest it leans on the cheap side, so investors are weighing how …

C1NC34 main company
Sharemaestro market context Trend signal active 52 weeks +117.4% C1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Stock index futures largely flat after S&P 500 closes at record high

[Wall Street New York stock exchange stock market] alexsl Stock index futures were muted on Friday after the S&P 500 closed at a record high in the previous session. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.12%, S&P 500 futures (SPX [https://seekingalpha.com/symbol/SPX]) +0.02%, and Nasdaq futures (US100:IND) …

I1NC34 mentioned A1LG34 mentioned
Sharemaestro market context Trend signal active 52 weeks +33.3% · Next-week setup negative 25.4% I1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Did New 7UP Formula, Dr Pepper Shakes and Board Addition Just Shift Keurig Dr Pepper's (KDP) Investment Narrative?

Keurig Dr Pepper has recently reported second-quarter 2026 results showing sales of US$7.31 billion and net income of US$142 million, while rolling out a lime-led reformulation of 7UP and partnering with Portillo's on limited-time Dr Pepper shakes in the U.S. Alongside these product moves, …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics?

On July 20, Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Incyte Corporation (NASDAQ:INCY) announced a global collaboration and licensing deal to develop a subcutaneous formulation of Incyte's INCA033989. The first-in-class monoclonal antibody targets mutant calreticulin (mutCALR)-expressing myeloproliferative neoplasms. By utilizing Halozyme's proprietary ENHANZE drug delivery technology, …

I1NC34 main company
Sharemaestro market context Trend signal active 52 weeks +33.3% · Next-week setup negative 25.4% I1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?

On July 23, Genmab A/S (NASDAQ:GMAB) and AbbVie Inc. (NYSE:ABBV) clarified a key clinical setback regarding their jointly developed T-cell engaging bispecific antibody, epcoritamab (DuoBody-CD3xCD20). The Phase 3 EPCORE DLBCL-1 study evaluated epcoritamab monotherapy against investigator's choice of chemoimmunotherapy in transplant-ineligible adults with relapsed/refractory …

ABBV34 main company
Sharemaestro market context Trend signal active 52 weeks +14.4% ABBV34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Johnson & Johnson (JNJ)’s $5.5B Talc Settlement: Turning Point or Temporary Relief?

The World Health Organization projects that the share of the world's population aged 60 years and older will almost double from 12% in 2015 to 22% by 2050. The Population Reference Bureau expects the number of Americans aged 65 and older to climb from …

JNJB34 main company
Sharemaestro market context Trend signal active 52 weeks +40.9% · Next-week setup negative 44.7% JNJB34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Cardinal Health Stock Hits a Record High After Earnings: Is CAH Still a Buy?

Cardinal Health CAH gave investors plenty to like in its fiscal fourth-quarter report this week, sending shares to a record high of $258 as Wall Street digests another earnings beat and an encouraging fiscal 2027 outlook. The Dividend Aristocrat's quarterly sales came in below …

C1AH34 main company
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine

Two biopharma giants, Merck & Co., Inc. (NYSE:MRK) and Gilead Sciences, Inc. (NASDAQ:GILD), are proving that in modern drug development, the biggest catalyst isn't always competing head-to-head; it is knowing when to join forces. While both companies reported their first-quarter 2026 earnings earlier this …

GILD34 main company
Sharemaestro market context Price below Trend Line 52 weeks +8.3% GILD34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth?

AbbVie Inc. (NYSE:ABBV) reported its first-quarter 2026 financial results, delivering worldwide net revenues of $15.002 billion, an increase of 12.4% on a reported basis (10.3% operationally). The company posted GAAP diluted EPS of $0.39 and adjusted diluted EPS of $2.65, which exceeded internal expectations …

ABBV34 main company
Sharemaestro market context Trend signal active 52 weeks +14.4% ABBV34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Gossamer Bio (GOSS) Reports Q2 Loss, Tops Revenue Estimates

Gossamer Bio (GOSS) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …

V2EE34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks -28.3% · Next-week setup negative 35.8% V2EE34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Merck (MRK) Stock Fair Value Edges Higher After Analysts Back Pipeline Progress

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Price target commentary for Merck has shifted toward a US$140 to US$155 range, anchored by a modest uplift in fair value from US$132.78 to …

MRCK34 main company
Sharemaestro market context Trend signal active 52 weeks +46.5% MRCK34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

Expands the solutions available to veterinarians to help address New World screwworm and gives added confidence for pet owners whose dogs and puppies are already receiving Simparica Trio Milestone demonstrates Zoetis' coordinated multi-species response to address New World screwworm across both companion animals and …

Z1TS34 main company
Sharemaestro market context Price below Trend Line 52 weeks -55.1% Z1TS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Novo Nordisk Stock Slips as Pill Strategy Reframes Obesity Race

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish obesity-drug giant behind Wegovy and Ozempic, slipped approximately 1% Thursday morning as CEO Mike Doustdar tried to reset the market's thinking about the obesity race. His pitch: stop treating Novo versus Eli Lilly …

N1VO34 main company
Sharemaestro market context Price above Trend Line 52 weeks -13.6% N1VO34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Sixty Compton, California Students to be Selected for Leadership and Health Advocacy Training, Powered by Health Net's $412,000 Investment

The company's investment in The Los Angeles Trust for Children's Health will help students build leadership skills, learn to support their peers and connect to local health care services LOS ANGELES, Aug. 11, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal …

C1NC34 mentioned
Sharemaestro market context Trend signal active 52 weeks +117.4% C1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?

Stryker Corporation SYK entered the second half of 2026 with momentum restored after the March cybersecurity disruption. Second-quarter sales, earnings and margins improved as production recovered, while management narrowed its full-year outlook. The next test is execution. Stryker must keep normalizing production, convert elevated …

S1YK34 main company
Sharemaestro market context Price above Trend Line 52 weeks -15.8% S1YK34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?

Stryker Corporation SYK shares have risen 13.6% in the past three months, outpacing the Zacks Medical sector's 12.9% gain and the S&P 500's 1.7% advance. The move has coincided with a sharper operating recovery after a difficult first quarter. The investor question is whether …

S1YK34 main company
Sharemaestro market context Price above Trend Line 52 weeks -15.8% S1YK34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

LQDA Q2 Earnings Top, Strong Yutrepia Sales Fuel Top-Line Growth

Liquidia Corporation LQDA reported second-quarter 2026 earnings per share (EPS) of 74 cents, which topped the Zacks Consensus Estimate of 70 cents. In the year-ago quarter, the company reported a loss per share of 49 cents. Total revenues surged to $171.7 million from $8.8 …

U2TH34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks +60.3% · Next-week setup negative 21.9% U2TH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

S&P 500 tags an all-time high and these 20 names have helped fuel the rally

[S&P Market Index Concept with Financial Graphs] AlexSecret The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) climbed to a fresh all-time high of 7,816.70 on Thursday, surpassing its prior record of 7,793.68 set on August 5. The benchmark advanced 0.6% for the session and is now up …

M1RN34 mentioned
Sharemaestro market context Trend signal active 52 weeks +95.6% M1RN34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is Novo Nordisk's Wegovy-Fueled Rebound Evaporating?

Novo Nordisk (NYSE: NVO) posted strong first-quarter results and performed fairly well in the month that followed its first-quarter update. However, the company's most recent financial update, for the second quarter, erased much of those gains. In both cases, the market's reaction was largely …

N1VO34 main company
Sharemaestro market context Price above Trend Line 52 weeks -13.6% N1VO34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

Pediatrix Medical Group, Inc. MD is a physician services provider company that offers a range of services across various specialties, including obstetrics, maternal-fetal medicine and neonatology, complemented by multiple pediatric subspecialties. The company has gained 23.9% in the year-to-date period, outperforming the industry's 1.2% …

C1NC34 mentioned
Sharemaestro market context Trend signal active 52 weeks +117.4% C1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Carolina Complete Health Supports Young Leaders Through AMEXCAN Summer Camp

Sponsorship helped 24 children from coastal North Carolina participate in educational, cultural and leadership-building activities CHARLOTTE, N.C., Aug. 13, 2026 /PRNewswire/ -- Carolina Complete Health, a subsidiary of the Centene Corporation (NYSE: CNC), sponsored the AMEXCAN Summer Camp, helping provide 24 children from coastal …

C1NC34 main company
Sharemaestro market context Trend signal active 52 weeks +117.4% C1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Novo Nordisk (CPSE:NOVO B) Sees New Pressure In Weight Loss Drugs

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Novo Nordisk (CPSE:NOVO B) faces fresh competition as the UK's MHRA approves Eli Lilly's oral weight loss therapy Foundayo for use in the …

N1VO34 main company
Sharemaestro market context Price above Trend Line 52 weeks -13.6% N1VO34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

UnitedHealth faces shareholder suit accusing corporate governance failures

[UnitedHealthcare headquarters in Minnetonka, Minnesota, USA] JHVEPhoto/iStock Editorial via Getty Images UnitedHealth Group (UNH [https://seekingalpha.com/symbol/UNH]) is facing an amended shareholder lawsuit that accuses the insurer of knowing about serious governance issues and doing little to ensure compliance, leading to significant losses in stock value. …

UNHH34 main company
Sharemaestro market context Trend signal active 52 weeks +26.7% UNHH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Can Humana Improve Caregiver Retention With HealthStream Deal?

Humana Inc.'s HUM Medicaid managed care plan, Humana Healthy Horizons, is teaming up with HealthStream in Indiana to strengthen the state's home-care workforce. Under the initiative, Humana is sponsoring 1,000 Home Health Aide scholarships, helping remove financial barriers for people entering the caregiving field. …

H1UM34 main company
Sharemaestro market context Trend signal active 52 weeks +26.2% H1UM34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

Revvity, Inc. RVTY recently announced the launch of the SuperFlex prenatal screening system, a compact, CE-IVDR-certified automated immunoassay instrument designed to expand access to prenatal and preeclampsia testing. Purpose-built for small to mid-sized laboratories and clinics, the platform is intended to bring reliable, rapid …

R1VT34 main company C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 34.8% R1VT34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation

Investing.com -- Wolfe Research upgraded two major pharmaceutical companies to Outperform on Thursday, citing stronger growth prospects, attractive valuations and a series of upcoming clinical catalysts. For Biogen, Wolfe raised its rating from Peer Perform and set a $300 price target, arguing that the …

BIIB34 mentioned
Sharemaestro market context Trend signal active 52 weeks +38.9% BIIB34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Wall Street Bulls Look Optimistic About Medtronic (MDT): Should You Buy?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before …

MDTC34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks -10.3% MDTC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

MHS Serves Announces Recipients of over $2 Million Investment in Hoosier Employment

INDIANAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Managed Health Services (MHS), a managed care entity that has been proudly serving the state of Indiana for 30 years and a Centene (NYSE: CNC) company, is proud to announce the recipients of the MHS Serves Workforce Support …

C1NC34 main company
Sharemaestro market context Trend signal active 52 weeks +117.4% C1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Can BWX Technologies' Nuclear Medicine Expansion Boost Growth?

BWX Technologies, Inc. BWXT is broadening its commercial nuclear portfolio through expanded capabilities in nuclear medicine and medical radioisotopes. The company's acquisition of Kinectrics in May 2025 added capabilities in the production and supply of isotopes for the radiopharmaceutical industry, enabling BWXT to expand …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context